Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
CN¥46.30 - CN¥88.38
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | CN¥30.75B |
EV | CN¥29.95B |
Shares Outstanding | 406.80M |
Beta | 0.23 |
Analyst Rating | BUY |
Analyst Target Price | CN¥84.34 |
P/E 2025E | 28.17x |
P/Revenue 2025E | 8.13x |
Revenue | 35.50% |
EPS | 65.20% |
Operating Cash Flow | 22.40% |
Free Cash Flow | 145.40% |
Revenue | 29.00% |
EPS | 33.70% |
Operating Cash Flow | 61.20% |
Free Cash Flow | 106.80% |
Gross Margin 2025E | 93.31% |
Net Profit Margin 2025E | 29.21% |
ROE 2025E | 31.87% |
ROCE 2024 | 37.37% |
DPS 2025E | CN¥0.61 |
Payout Ratio 2025E | 23.11% |
Div. Yield 2025E | 0.82% |
DPS Last 3Y CAGR | 83.70% |
Price
%
1M
3M
6M
1Y
3Y
5Y
Xiamen Amoytop Biotech Co., Ltd.
688278
Sector
Healthcare
Industry
Biotechnology
CEO
Sun, Li
Employees
2,423
Website
www.amoytop.comIPO Date
2020-01-17
Headquarters
No. 330 Wengjiao Road, Xinyang Industry Zone of Haicang, Xiamen, Fujian Province, 361022, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved